Detalhe da pesquisa
1.
TGFß attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Nature
; 554(7693): 544-548, 2018 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29443960
2.
Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis.
Value Health
; 26(10): 1485-1493, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414278
3.
The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Value Health
; 26(2): 216-225, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192293
4.
Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer.
Oncologist
; 27(3): 236-243, 2022 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274714
5.
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model.
Antimicrob Agents Chemother
; 61(11)2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28807912
6.
Validation of an Updated Algorithm to Identify Patients With Incident Non-Small Cell Lung Cancer in Administrative Claims Databases.
JCO Clin Cancer Inform
; 8: e2300165, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502111
7.
Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma.
J Med Econ
; 27(1): 738-745, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38686393
8.
Racial and Ethnic Inequities at the Practice and Physician Levels in Timely Next-Generation Sequencing for Patients With Advanced Non-Small-Cell Lung Cancer Treated in the US Community Setting.
JCO Oncol Pract
; 20(3): 370-377, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194619
9.
Reply to Hunsberger and Memoli, "Efficacy Analysis in Healthy-Volunteer Influenza Challenge Trials: Intention To Treat".
Antimicrob Agents Chemother
; 62(1)2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29269431
10.
Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple Sclerosis.
Drugs Real World Outcomes
; 10(4): 565-575, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733192
11.
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis.
Neurol Ther
; 11(1): 337-351, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020156
12.
The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis.
J Health Econ Outcomes Res
; 9(1): 111-116, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35586512
13.
Healthcare Resource Use and Burden Associated with Influenza Transmission Among Household Members with a Primary Infection: Commercial Claims Data Analysis.
Clinicoecon Outcomes Res
; 13: 335-342, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958880
14.
Association Between Medicare's National Coverage Determination and Utilization of Next-Generation Sequencing.
JCO Oncol Pract
; 17(11): e1774-e1784, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043456
15.
Identification and temporal trends of patients with neuromyelitis optica spectrum disorder in a US insurance claims database.
J Med Econ
; 24(1): 581-588, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879033
16.
A Cost-Effectiveness Framework for COVID-19 Treatments for Hospitalized Patients in the United States.
Adv Ther
; 38(4): 1811-1831, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650025
17.
The costs of care from a US claims database in patients with neuromyelitis optica spectrum disorder.
J Neurol Sci
; 427: 117553, 2021 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34224957
18.
Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder.
J Neurol Sci
; 427: 117530, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34111762
19.
Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.
JAMA Netw Open
; 4(12): e2138219, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34882180
20.
Estimated Impact of Public and Private Sector COVID-19 Diagnostics and Treatments on US Healthcare Resource Utilization.
Adv Ther
; 38(2): 1212-1226, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367984